Prognosis impact of multiple novel lymphocyte‐based inflammatory indices in patients with initially diagnosed coronary artery disease

This study aimed to evaluate six novel lymphocyte-based inflammatory markers (neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio, platelet-lymphocyte ratio PLR, systemic immune inflammation index SII, systemic inflammatory response index, and systemic immune inflammation response index SIIRI) in patients with newly diagnosed coronary artery disease CAD.